160 related articles for article (PubMed ID: 10994739)
1. Comparison of intratumoral distribution of 99mTc-MIBI and deoxyglucose in mouse breast cancer models.
Ohira H; Kubota K; Ohuchi N; Harada Y; Fukuda H; Satomi S
J Nucl Med; 2000 Sep; 41(9):1561-8. PubMed ID: 10994739
[TBL] [Abstract][Full Text] [Related]
2. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG.
Kubota R; Kubota K; Yamada S; Tada M; Takahashi T; Iwata R; Tamahashi N
J Nucl Med; 1995 Mar; 36(3):484-92. PubMed ID: 7884515
[TBL] [Abstract][Full Text] [Related]
3. The relationship between (99m)Tc-MIBI uptakes and tumor cell death/proliferation state under irradiation.
Zhu X; Wu H; Xia J; Zhao M; Xianyu Z
Cancer Lett; 2002 Aug; 182(2):217-22. PubMed ID: 12048168
[TBL] [Abstract][Full Text] [Related]
4. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake.
Kubota R; Kubota K; Yamada S; Tada M; Ido T; Tamahashi N
J Nucl Med; 1994 Jan; 35(1):104-12. PubMed ID: 8271030
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo tracer characteristics of an established multidrug-resistant human colon cancer cell line.
Lorke DE; Krüger M; Buchert R; Bohuslavizki KH; Clausen M; Schumacher U
J Nucl Med; 2001 Apr; 42(4):646-54. PubMed ID: 11337555
[TBL] [Abstract][Full Text] [Related]
6. Correlation between 99mTc-MIBI uptake and angiogenesis in MIBI-positive breast lesions.
Bekiş R; Degirmenci B; Aydin A; Ozdogan O; Canda T; Durak H
Nucl Med Biol; 2005 Jul; 32(5):465-72. PubMed ID: 15982577
[TBL] [Abstract][Full Text] [Related]
7. Applicability of 99mTc-HL91, a putative hypoxic tracer, to detection of tumor hypoxia.
Yutani K; Kusuoka H; Fukuchi K; Tatsumi M; Nishimura T
J Nucl Med; 1999 May; 40(5):854-61. PubMed ID: 10319761
[TBL] [Abstract][Full Text] [Related]
8. Autoradiography and radioscintigraphy of technetium-99m-sestamibi in c-neu transgenic mice.
Crane PD; Onthank DC; Bourque CR; Heminway SJ; Mazaika TJ; Leav I; Zambuto GF; Lazewatsky JL; Villamil-Perez L; Carroll TR
J Nucl Med; 1995 Oct; 36(10):1862-8. PubMed ID: 7562056
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of 99mTc-YIGSR and 99mTc-MIBI uptake in tumor cells.
Hu J; Lan X; Zhang Y; Gao Z; Wu J
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(6):712-4. PubMed ID: 16696334
[TBL] [Abstract][Full Text] [Related]
10. Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy.
Taki J; Sumiya H; Asada N; Ueda Y; Tsuchiya H; Tonami N
J Nucl Med; 1998 Jul; 39(7):1179-84. PubMed ID: 9669390
[TBL] [Abstract][Full Text] [Related]
11. Lack of correlation between tritiated deoxyglucose, thallium-201 and technetium-99m-MIBI cell incorporation under various cell stresses.
Slosman DO; Pugin J
J Nucl Med; 1994 Jan; 35(1):120-6. PubMed ID: 7505818
[TBL] [Abstract][Full Text] [Related]
12. Technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 uptake in rat myocardial cells.
Arbab AS; Koizumi K; Toyama K; Arai T; Araki T
J Nucl Med; 1998 Feb; 39(2):266-71. PubMed ID: 9476934
[TBL] [Abstract][Full Text] [Related]
13. Enhancing targeted radiotherapy by copper(II)diacetyl- bis(N4-methylthiosemicarbazone) using 2-deoxy-D-glucose.
Aft RL; Lewis JS; Zhang F; Kim J; Welch MJ
Cancer Res; 2003 Sep; 63(17):5496-504. PubMed ID: 14500386
[TBL] [Abstract][Full Text] [Related]
14. Uptake of 99mTc-MIBI and 99mTc-tetrofosmin into malignant versus nonmalignant breast cell lines.
Rodrigues M; Chehne F; Kalinowska W; Berghammer P; Zielinski C; Sinzinger H
J Nucl Med; 2000 Sep; 41(9):1495-9. PubMed ID: 10994728
[TBL] [Abstract][Full Text] [Related]
15. Dynamic coupling of 99mTc-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients.
Del Vecchio S; Zannetti A; Ciarmiello A; Aloj L; Caracò C; Fonti R; Botti G; D'Aiuto G; Salvatore M
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):809-14. PubMed ID: 12029556
[TBL] [Abstract][Full Text] [Related]
16. Assessment of radiotherapeutic effects on experimental tumors using 18F-2-fluoro-2-deoxy-D-glucose.
Abe Y; Matsuzawa T; Fujiwara T; Fukuda H; Itoh M; Yamada K; Yamaguchi K; Sato T; Ido T
Eur J Nucl Med; 1986; 12(7):325-8. PubMed ID: 3792361
[TBL] [Abstract][Full Text] [Related]
17. Correlation of 99mTc-sestamibi uptake with blood-pool and osseous phase 99mTc-MDP uptake in malignant bone and soft-tissue tumours.
Ozcan Z; Burak Z; Erinç R; Dirlik A; Başdemir G; Sabah D; Ozkiliç H
Nucl Med Commun; 2001 Jun; 22(6):679-83. PubMed ID: 11403180
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo study of 99mTc-MIBI encapsulated in PEG-liposomes: a promising radiotracer for tumour imaging.
Belhaj-Tayeb H; Briane D; Vergote J; Kothan S; Léger G; Bendada SE; Tofighi M; Tamgac F; Cao A; Moretti JL
Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):502-9. PubMed ID: 12536243
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma.
Fonti R; Del Vecchio S; Zannetti A; De Renzo A; Di Gennaro F; Catalano L; Califano C; Pace L; Rotoli B; Salvatore M
Eur J Nucl Med; 2001 Feb; 28(2):214-20. PubMed ID: 11303893
[TBL] [Abstract][Full Text] [Related]
20. 99mTc-sestamibi to monitor treatment with antisense oligodeoxynucleotide complementary to MRP mRNA in human breast cancer cells.
Kinuya S; Bai J; Shiba K; Yokoyama K; Mori H; Fukuoka M; Watanabe N; Shuke N; Michigishi T; Tonami N
Ann Nucl Med; 2006 Jan; 20(1):29-34. PubMed ID: 16485571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
